1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Lifitegrast
Trade Name:
Xiidra
Manufacturer/Distributor:
Shire Pharma Canada
Classification:
Lymphocyte function associated antigen-1 (LFA-1) antagonist
Miscellaneous anti-inflammatory agent
ATC Class:
S01XA25 - lifitegrast
Status:
active
Notice of Compliance (yyyy/mm/dd):
2017/12/22
Date Marketed in Canada (yyyy/mm/dd):
2017/12/22
Presentation:
Ophthalmic drops: 5%. DIN: 02471027
Comments:
For treatment of dry eye disease.
Back to:
Drug Product Listings 
